Epigenetic regulation of neonatal cardiomyocytes differentiation

Biochemical and Biophysical Research Communications

Volumn 400, Issue 2, 2010, Pages 278-283

  Kou, Cecy Ying Chuck ^a   Lau, Samantha Lai Yee ^a   Au, Ka Wing ^a   Leung, Pui Yin ^a   Chim, Stephen Siu Chung ^a   Fung, Kwok Pui ^a   Waye, Mary Miu Yee ^a   Tsui, Stephen Kwok Wing ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

5 Azacytidine; Acetylated histone; Chromatin structure; DNA methylation; Terminal differentiation

Indexed keywords

AZACITIDINE; DNA; DNA METHYLTRANSFERASE 1; HISTONE; METHYL CPG BINDING PROTEIN; METHYL CPG BINDING PROTEIN 1; METHYL CPG BINDING PROTEIN 2; METHYL CPG BINDING PROTEIN 3; UNCLASSIFIED DRUG; DNA (CYTOSINE 5) METHYLTRANSFERASE;

ACETYLATION; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL DIFFERENTIATION; CHROMATIN STRUCTURE; CONTROLLED STUDY; DNA METHYLATION; DNA SYNTHESIS; GENE OVEREXPRESSION; GENETIC REGULATION; HEART DEVELOPMENT; HEART MUSCLE CELL; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAT; UPREGULATION; ANIMAL; CYTOLOGY; DRUG EFFECTS; GENETIC EPIGENESIS; GENETICS; METABOLISM; SPRAGUE DAWLEY RAT;

ANIMALS; AZACITIDINE; CELL DIFFERENTIATION; DNA METHYLATION; DNA-CYTOSINE METHYLASES; EPIGENESIS, GENETIC; HISTONES; METHYL-CPG-BINDING PROTEIN 2; MYOCYTES, CARDIAC; RATS; RATS, SPRAGUE-DAWLEY;

RATTUS;

EID: 77956740777     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.08.064     Document Type: Article

References (25)

1. Soonpaa M.H., Field L.J. Survey of studies examining mammalian cardiomyocyte DNA synthesis. Circ. Res. 1998, 83:15-26.
2. Clubb F.J., Bishop S.P. Formation of binucleated myocardial cells in the neonatal rat. An index for growth hypertrophy. Lab. Invest. 1984, 50:571-577.
3. Li F., Wang X., Capasso J.M., Gerdes A.M. Rapid transition of cardiac myocytes from hyperplasia to hypertrophy during postnatal development. J. Mol. Cell. Cardiol. 1996, 28:1737-1746.
4. Ehrlich M. Expression of various genes is controlled by DNA methylation during mammalian development. J. Cell. Biochem. 2003, 88:899-910.
5. Okano M., Bell D.W., Haber D.A., Li E. DNA methyltransferase Dnmt3A and Dnmt3B are essential for de novo methylation and mammalian development. Cell 1999, 99:247-257.
6. Bestor T.H. The DNA methyltransferases of mammals. Hum. Mol. Genet. 2000, 9:2395-2402.
7. Nan X., Ng H.H., Johnson C.A., Laherty C.D., Turner B.M., Eisenman R.N., Bird A. Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature 1998, 393:386-389.
8. Ng H.H., Bird A. DNA methylation and chromatin modification. Curr. Opin. Genet. Dev. 1999, 9:158-163.
9. Lopez-Serra L., Ballestar E., Ropero S., Setien F., Billard L.-M., Fraga1 M.F., Lopez-Nieva1 P., Alaminos M., Guerrero D., Dante R., Esteller M. Unmasking of epigenetically silenced candidate tumor suppressor genes by removal of methyl-CpG-binding domain proteins. Oncogene 2008, 27:3555-3566.
10. Chim S.S., Fung K.P., Waye M.M.Y., Lee C.Y., Tsui S.K.W. Expression of replication factor C 40kDa subunit is down-regulated during neonatal development in rat ventricular myocardium. J. Cell. Biochem. 2000, 78:533-540.
11. Chim S.S., Cheung S.S.F., Tsui S.K.W. Differential gene expression of rat neonatal heart analyzed by suppression subtractive hybridization and expressed sequence tag sequencing. J. Cell. Biochem. 2000, 80:24-36.
12. Ingrosso D., Cimmino A., Perna A.F., Masella L., De Santo N.G., De Bonis M.L., Vacca M., D'Esposito M., D'Urso M., Galletti P., Zappia V. Folate treatment and unbalanced methylation and changes of allelic expression induced by hyperhomocysteinaemia in patients with uraemia. Lancet 2003, 361:1693-1699.
13. Jenuwein T., Allis C.D. Translating the histone code. Science 2001, 293:1074-1080.
14. Garcia-Ramirez M., Rocchini C., Ausio J. Modulation of chromatin folding by histone acetylation. J. Biol. Chem. 1995, 270:17923-17928.
15. Lee D.Y., Hayes J.J., Pruss D., Wolffe A.P. A positive role for histone acetylation in transcription factor access to nucleosomal DNA. Cell 1993, 72:73-84.
16. Workman J.L. Nucleosome displacement in transcription. Genes Dev. 2006, 20:2009-2017.
17. Lachner M., Jenuwein T. The many faces of histone lysine methylation. Curr. Opin. Cell Biol. 2002, 14:286-298.
18. Johnson L., Cao X., Jacobsen S. Interplay between two epigenetic marks. DNA methylation and histone H3 lysine 9 methylation. Curr. Biol. 2002, 12:1360-1367.
19. Fatemi M., Wade P.A. MBD family proteins: reading the epigenetic code. J. Cell Sci. 2006, 119:3033-3037.
20. Nan X., Campoy F.J., Bird A. MeCP2 is a transcriptional repressor with abundant binding sites in genomic chromatin. Cell 1997, 88:471-481.
21. Glaze D.G. Neurophysiology of Rett syndrome. J. Child Neurol. 2005, 20:740-746.
22. Jones P.L., Veenstra G.J., Wade P.A., Vermaak D., Kass S.U., Landsberger N., Strouboulis J., Wolffe A.P. Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription. Nat. Genet. 1998, 19:187-191.
23. McKinsey T.A., Olson E.N. Cardiac histone acetylation - therapeutic opportunities abound. Trends Genet. 2004, 20:206-213.
24. Berry J.M., Cao D.J., Rothermel B.A., Hill J.A. Histone deacetylase inhibition in the treatment of heart disease. Expert Opin. Drug Saf. 2008, 7:53-67.
25. Papait R., Condorelli G. Epigenetics in heart failure. Ann. NY Acad. Sci. 2010, 1188:159-164.